4//SEC Filing
Jaeger Frank 4
Accession 0000899243-21-048212
CIK 0001817944other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 7:02 PM ET
Size
7.7 KB
Accession
0000899243-21-048212
Insider Transaction Report
Form 4
Jaeger Frank
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-12-11+72,500→ 72,500 totalExercise: $4.78Exp: 2031-12-10→ Common Stock (72,500 underlying) - Award
Common Stock
2021-12-11+29,000→ 29,000 total
Footnotes (2)
- [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 29,000 shares on 12/11/2021, of which 25% vest on 9/9/2022, and the remaining shares vest in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.
- [F2]These options were granted under the 2021 Plan and vest (i) 25% on 9/9/2022 and (ii) with the remainder vesting in 36 equal monthly installments thereafter subject to the Reporting Person continuing to have a service relationship as of each such vesting date.
Documents
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeother
Related Parties
1- filerCIK 0001878385
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 7:02 PM ET
- Size
- 7.7 KB